United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:45PM EDT. Market open.
| Previous close | 235.95 |
| Open | 236.59 |
| Bid | 235.50 x 100 |
| Ask | 236.13 x 100 |
| Day's range | 234.68 - 237.53 |
| 52-week range | 204.44 - 261.54 |
| Volume | |
| Avg. volume | 469,208 |
| Market cap | 11.086B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 11.89 |
| EPS (TTM) | 19.82 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 292.25 |
ZacksStevanato Group (STVN) to Report Q1 Results: What You Should Expect
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksWill United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ZacksUnited Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.